NESN Stock Analysis: Nestle S.A. | SW

Packaged Foods | SW, Switzerland | Market Cap: 195.489m CHF | 12M Return: 5.6% | CH0038863350 | Charts, Fundamentals & Technical Analysis

Coffee, Confectionery, Petcare, Nutrition
Total Rating 56
Safety 79
Buy Signal -0.12
Packaged Foods
Industry Rotation: +3.0
Market Cap: 235B
Avg Turnover: 230M
Risk 3d forecast
Volatility19.3%
VaR 5th Pctl3.01%
VaR vs Median-4.80%
Reward TTM
Sharpe Ratio0.17
Rel. Str. IBD36.9
Rel. Str. Peer Group70.9
Character TTM
Beta-0.272
Beta Downside-0.288
Hurst Exponent0.388
Drawdowns 3y
Max DD27.74%
CAGR/Max DD-0.25
CAGR/Mean DD-0.45

Warnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.7 years of data

Jan -0.1% 14
Feb -4.2% 22
Mar +1.3% 29
Apr +3.9% 77
May +0.9% 18
Jun -0.8% 20
Jul -0.2% 10
Aug -0.1% 7
Sep -2.5% 56
Oct -0.6% 0
Nov -2.0% 25
Dec -1.3% 15

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: NESN Nestle S.A.

Nestlé S.A. is a Swiss-headquartered multinational that manufactures and distributes food, beverage, and nutritional science products across more than a dozen major markets, including the United States, Brazil, Mexico, Greater China, and key European countries. Founded in 1866 and based in Vevey, Switzerland, the company operates one of the broadest brand portfolios in the global packaged foods industry, spanning cereals, chocolate, coffee, dairy, ice cream, nutrition, petcare, water, and culinary products under names such as Nescafé, KitKat, Maggi, Purina, and S.Pellegrino.

As a mega-cap consumer staples issuer, Nestlé generates revenue across multiple product categories and geographies, with petcare, coffee, and nutrition representing core growth segments. The packaged foods and meats sub-industry is typically characterized by stable, recurring demand and brand-led pricing power, though it faces ongoing pressure from shifting consumer preferences toward healthier, plant-based, and premium offerings, as reflected in Nestlés expansion of plant-based and nutrition-focused product lines.

Headlines to Watch Out For
  • Purina pet care drives organic growth above group average
  • Cocoa costs surge pressures confectionery and chocolate margins
  • Greater China sales decline weighs on emerging markets revenue
Piotroski VR-10 (Strict) 5.0
Net Income: 7.44b TTM > 0 and > 6% of Revenue
FCF/TA: 0.10 > 0.02 and ΔFCF/TA 2.57 > 1.0
NWC/Revenue: -8.73% < 20% (prev -14.76%; Δ 6.03% < -1%)
CFO/TA 0.13 > 3% & CFO 16.4b > Net Income 7.44b
Net Debt (56.7b) to EBITDA (16.6b): 3.41 < 3
Current Ratio: 0.83 > 1.5 & < 3
Outstanding Shares: last quarter (2.57b) vs 12m ago -1.53% < -2%
Gross Margin: 45.45% > 18% (prev 46.55%; Δ -1.10% > 0.5%)
Asset Turnover: 68.37% > 50% (prev 69.72%; Δ -1.35% > 0%)
Interest Coverage Ratio: 7.41 > 6 (EBIT TTM 13.0b / Interest Expense TTM 1.76b)
Altman Z'' 2.09
A: -0.06 (Total Current Assets 37.6b - Total Current Liabilities 45.3b) / Total Assets 128b
B: 0.46 (Retained Earnings 58.8b / Total Assets 128b)
C: 0.10 (EBIT TTM 13.0b / Avg Total Assets 129b)
D: 0.30 (Book Value of Equity 29.2b / Total Liabilities 98.9b)
Altman-Z'' = 2.09 = BBB
Beneish M -3.00
DSRI: 1.08 (Receivables 11.3b/10.7b, Revenue 88.4b/90.7b)
GMI: 1.02 (GM 46.55% / 45.45%)
AQI: 0.93 (AQ_t 0.47 / AQ_t-1 0.50)
SGI: 0.97 (Revenue 88.4b / 90.7b)
TATA: -0.07 (NI 7.44b - CFO 16.4b) / TA 128b)
Beneish M = -3.00 (Cap -4..+1) = A
What is the price of NESN shares?

As of October 12, 2026, the stock is trading at CHF 76.04 with a total of 2,539,585 shares traded. Over the past week, the price has changed by +1.68%, over one month by -2.17%, over three months by -8.73% and over the past year by +5.55%.

Current recommended Stop Loss: 74.60 (which is 1.9% or 1.2 ATR below the current price).

Is NESN a buy, sell or hold?

Nestle S.A. has no consensus analysts rating.

Nestle S.A. (NESN) - Fundamental Data Overview as of 10 October 2026
Market Cap USD = 235b (195b CHF * 1.2042 CHF.USD)
P/E Trailing = 26.2976
P/E Forward = 16.1551
P/S = 2.2021
P/B = 6.7847
P/EG = 1.8775
Revenue TTM = 88.4b CHF
EBIT TTM = 13.0b CHF
EBITDA TTM = 16.6b CHF
Long Term Debt = 44.0b CHF (from longTermDebt, last fiscal year)
Short Term Debt = 16.3b CHF (from shortTermDebt, last quarter)
Debt = 62.8b CHF (from shortLongTermDebtTotal, last quarter)
Net Debt = 56.7b CHF (calculated: Debt 62.8b - CCE 6.13b)
Enterprise Value = 252b CHF (195b + Debt 62.8b - CCE 6.13b)
Interest Coverage Ratio = 7.41 (Ebit TTM 13.0b / Interest Expense TTM 1.76b)
EV/FCF = 20.15x (Enterprise Value 252b / FCF TTM 12.5b)
FCF Yield = 4.96% (FCF TTM 12.5b / Enterprise Value 252b)
FCF Margin = 14.17% (FCF TTM 12.5b / Revenue TTM 88.4b)
Net Margin = 8.42% (Net Income TTM 7.44b / Revenue TTM 88.4b)
Gross Margin = 45.45% ((Revenue TTM 88.4b - Cost of Revenue TTM 48.2b) / Revenue TTM)
Gross Margin QoQ = 46.37% (prev 44.58%)
Tobins Q-Ratio = 1.96 (Enterprise Value 252b / Total Assets 128b)
Interest Expense / Debt = 2.80% (Interest Expense 1.76b / Debt 62.8b)
Taxrate = 22.88% (2.28b / 9.96b)
NOPAT = 10.0b (EBIT 13.0b * (1 - 22.88%))
Current Ratio = 0.83 (Total Current Assets 37.6b / Total Current Liabilities 45.3b)
Debt / Equity = 2.15 (Debt 62.8b / totalStockholderEquity, last quarter 29.2b)
Debt / EBITDA = 3.41 (Net Debt 56.7b / EBITDA 16.6b)
Debt / FCF = 4.53 (Net Debt 56.7b / FCF TTM 12.5b)
Total Stockholder Equity = 31.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.76% (Net Income 7.44b / Total Assets 128b)
RoE = 23.47% (Net Income TTM 7.44b / Total Stockholder Equity 31.7b)
RoCE = 17.22% (EBIT 13.0b / Capital Employed (Equity 31.7b + L.T.Debt 44.0b))
RoIC = 10.57% (NOPAT 10.0b / Invested Capital 95.0b)
WACC = 4.33% (E(195b)/V(258b) * Re(5.03%) + D(62.8b)/V(258b) * Rd(2.80%) * (1-Tc(0.23)))
Discount Rate = 5.03% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.67 | Cagr: -3.44%
[DCF] Terminal Value 77.97% ; FCFF base≈11.2b ; Y1≈12.9b ; Y5≈19.0b
[DCF] Fair Price = 88.97 (EV 286b - Net Debt 56.7b = Equity 229b / Shares 2.57b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 39.99 | EPS CAGR: 13.68% | SUE: N/A | # QB: 0
Revenue Correlation: -99.16 | Revenue CAGR: -2.10% | SUE: 1.08 | # QB: 1
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=4.50 | Chg30d=+0.41% | Revisions=+57% | GrowthEPS=+1.7% | GrowthRev=+0.6%
EPS next Year (2027-12-31): EPS=4.82 | Chg30d=+0.09% | Revisions=+50% | GrowthEPS=+7.2% | GrowthRev=+3.1%
[Analyst] Revisions Ratio: +70% (up=7, down=0)